Priscilla K. Brastianos, MD, explains the differences between low-grade meningiomas and aggressive high-grade tumors.
Priscilla K. Brastianos, MD
Advertisement
Articles by Priscilla K. Brastianos, MD
Priscilla K. Brastianos, MD, reviews recent findings in high-grade meningiomas, including data generated in her laboratory.
Advertisement
Latest Updated Articles
- Dr. Brastianos on Recent Data in High-Grade Meningiomas
Published: April 4th 2023 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
2
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
3
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
4
Orca-T With Reduced-Intensity Conditioning Yields Robust Efficacy in Hematologic Malignancies
5